Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Pushkal Garg Insider Profile
4 Followers
Pushkal Garg, Director at SQZ Biotechnologies, holds ― shares in SQZ Biotechnologies (Ticker: SQZB), holds 14.10K shares in Alnylam Pharma (Ticker: ALNY). Most recently, Pushkal Garg ― shares of SQZ Biotechnologies on ― for an estimated value of ―.
Profitable Transactions
3 out of 3 Profitable Transactions
Average Return
+18.10%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Pushkal Garg holds in companies
Most Profitable Insider Trade
The most profitable trade made by Pushkal Garg
Pushkal Garg's Trading History
SQZ Biotechnologies
―
Director
―
―
Alnylam Pharma
Mar 05, 2024
CMO & EVP Dev & Med Affairs
Uninformative Buy
―
$2.03M
List of latest transactions for each holding click on a transaction to see Pushkal Garg's performance on stock
You May Also Like
Pushkal Garg insider profile FAQ
What is the percentage of profitable transactions made by Pushkal Garg?
The percentage of profitable transactions made by Pushkal Garg is 100%.
What is the average return per transaction made by Pushkal Garg?
The average return per transaction made by Pushkal Garg is 18.10%.
What stocks does Pushkal Garg hold?
Pushkal Garg holds: SQZB, ALNY stocks.
What was Pushkal Garg’s latest transaction?
Pushkal Garg latest transaction was an Uninformative Buy of ―.
What was Pushkal Garg's most profitable transaction?
Pushkal Garg’s most profitable transaction was an Informative Sell of ALNY stock on April 28, 2023. The return on the trade was 28.00%.
What is Pushkal Garg's role in SQZ Biotechnologies?
Pushkal Garg's role in SQZ Biotechnologies is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.